Objectives-To determine whether the qualitative sonographic appearance of slow deep venous flow in the lower extremities correlates with quantitative slow flow and an increased risk of deep venous thrombosis (DVT) in oncology patients.
risk stratification algorithms such as the Wells score or Hamilton score and new medical therapies for venous thrombosis. 2, 3 The clinical and research focus on deep venous thrombosis (DVT) has been driven by its associated substantial morbidity, mortality, and resource use across worldwide populations 4 ; specifically, DVT from the lower extremities accounts for approximately 80% of venous thromboembolism, with an estimated venous thromboembolism incidence of 900,000 per year. 5 Of these cases, 20% are attributed to malignancy. 6 This increased risk is elevated further in patients receiving chemotherapy, more so than the risk associated with congestive heart failure or the general increased risk associated with hospitalization. 7, 8 Numerous other risk factors for DVT have been identified, such as prolonged intensive care unit admission, immobility, history of DVT/venous thromboembolism, infection, and the presence of a central venous catheter. 5, 9, 10 Despite the important progress that has been made in understanding DVT, there are many aspects of DVT that require further evaluation. Slow venous flow, observed on Doppler sonography, is one such area needing further assessment, specifically as it relates to DVT. The concept of "sluggish" venous flow, or "stasis," has been recognized for centuries but has been studied in only a few patient groups, with limited scientific rigor. 11 A few previous studies have directly evaluated slow venous flow, and others have indirectly assessed patients at risk with presumed or confirmed venous stasis. Direct evaluations include work by Lozano et al, 12 who assessed 218 patients in the immediate postoperative period after ipsilateral inguinal hernioplasty with mesh placement. That study demonstrated short-term slowing of deep venous flow without an increased incidence of venous thromboembolism and near normalization of flow 7 days thereafter. 12 An even shorter duration of slow venous flow was shown during intraperitoneal insufflation for laparoscopy, without evidence of an increased rate of DVT. 13 However, medical practice commonly attributes increased risk of DVT to venous stasis or factors presumed to decrease deep venous flow. For example, multiple authors have evaluated slow venous flow in the surgical setting, with mention of increased associated risk of DVT, but they have provided only limited supporting evidence. [14] [15] [16] Indirect evaluations of venous stasis include work by Scurr et al, 17 who evaluated an otherwise normal population of airline passengers and showed an increased incidence of DVT.
The potential correlation of slow venous flow on sonography with increased risk of subsequent DVT formation would have important implications for patient prognosis and management. Therefore, in this study, we evaluated whether the qualitative sonographic appearance of slow deep venous flow in the lower extremities correlated with quantitative measures of slow flow and whether there was an increased risk of subsequent DVT in oncology patients. To our knowledge, this study is the first such evaluation of a general oncologic population and the largest study to evaluate slow deep venous flow identified sonographically.
Materials and Methods
In this Institutional Review Board-approved and Health Insurance Portability and Accountability Act-compliant retrospective study, 2 groups of lower extremity venous Doppler sonographic examinations were reviewed by 2 radiologists: those of consecutive patients with reported slow or sluggish venous flow, who were identified for analysis on the basis of a search of radiology reports between January 1, 2008, and January 1, 2015, and a group of consecutive patients without reported abnormal venous flow (normal flow group) between February 1, 2013, and November 31, 2014.
All examinations were performed in our American College of Radiology-accredited department, most examinations by sonographers certified in the vascular registry of the American Registry for Diagnostic Medical Sonography, under the supervision of the senior author (>30 years of ultrasound experience). Equipment used was either iU22 (Philips Healthcare, Bothell, WA) or LOGIQ E9 (GE Healthcare, Milwaukee, WI). Most examinations were performed with linear transducers with a frequency range of 9-12 MHz. A small number required curved array transducers with a frequency range of 2-5 MHz for limited sections of the femoral veins. When presets on the machines were judged inadequate by the sonographer, individual gain and focal zone adjustments were made specifically for that patient. Real-time cine loop images are standard in our department in equivocal cases and were reviewed for this study; this process enabled the differentiation of sonographic artifacts from slow flow in all cases.
The presence or absence of qualitative slow venous flow and absence of initial or recent DVT (within 30 days), per the official radiology report and clinic notes, were confirmed with reevaluation by 2 radiologists (V.D.A., a senior radiology resident, and C.T.J., a boardcertified radiologist with an abdominal imaging fellowship); potential discrepancies were addressed through consensus reevaluation (<1% of all cases reviewed) without any patients being excluded from either group. Slow venous flow without a thrombus was qualitatively defined as amorphous echogenicity, greater than that of the adjacent artery, throughout the fully compressible venous lumen (Figure 1) . In many cases, cine imaging had been performed, but it was not used as a standard in our study, given that cine imaging was not performed in all cases. Per departmental protocol, in addition to the common femoral, femoral, and popliteal levels, the deep calf veins were assessed whenever focal symptoms were attributed to a region below the knee.
Peak venous flow velocities were recorded at the common femoral, femoral, and popliteal levels based on standard spectral waveforms.
Each patient had clinical or sonographic follow-up, with the number of days between the incident sonographic examination and most recent encounter recorded.
Medical records were reviewed retrospectively to identify, at the time of the incident sonographic examination, whether the patient was an inpatient or outpatient. Patients' age, sex, acute condition, mobility status, notable medical history, medications, primary tumor histologic findings, history of chemotherapy within 30 days, and cross-sectional imaging within 30 days (before or after) were recorded. Reports and images from any available cross-sectional examinations of the abdomen/pelvis were reviewed for the possible presence of a lesion (eg, tumor, lymphadenopathy, or stenosis) that could obstruct venous flow. The D-dimer level and, if medications included warfarin, international normalized ratio were recorded if obtained within 7 days of the sonographic examination.
The descriptive statistics for continuous clinical factors were summarized and compared between DVT and non-DVT groups by a 2-sample t test. The associations between DVT and other factors such as the presence of slow venous flow or a dichotomized peak velocity were examined by the Fisher exact test, as was applied for comparison of all categorical variables. A 2-sample t test or Wilcoxon rank sum test was applied for comparison of continuous variables. The P values were adjusted for multiple testing by the Benjamini-Hochberg procedure. 18 Logistic regression was applied to determine whether age and sex correlates with the presence of slow flow. A 2-sample t test was used for peak velocity comparison of slow flow versus normal groups and DVT versus non-DVT. The optimal cutoff point for the peak velocity was determined by the Youden index. 19, 20 All of the analyses were conducted in R version 3.1.2 statistical software with the pROC and OptimalCutpoints packages (R Foundation for Statistical Computing, Vienna, Austria). P .05 or smaller was considered statistically significant.
Results
The study group consisted of 482 consecutive patients with reported slow or sluggish venous flow (46% were bilateral examinations) and 493 consecutive patients without reported abnormal venous flow (normal flow; 55% were bilateral examinations), for a total of 975 patients whose venous flow was assessed by sonography. Patient characteristics, cancer diagnosis frequencies, and characteristics of patients with subsequent DVT development are shown in Tables 1-3 . The top 4 indications for the incident sonographic examinations were edema, pain, shortness of breath, and pulmonary embolism for both the normal and slow-flow groups, accounting for 89% and 78% of all indications, respectively. No significant difference in age was present between the groups. More men than women had slow venous flow (odds ratio, 1.5; 95% confidence interval, 1.163-1.937; P 5 .002). No correlation was found between DVT and patient age, primary tumor site, tumor histopathologic findings, or sex.
The increased rate of subsequent DVT development in the slow-flow group (21 of 482 [4.36%]) compared with the normal-flow group (11 of 493 [2.23%]) was statistically significant (P 5 .0456). When assessing values within each flow group, no significant difference in peak velocities was found between patients who did or did not develop subsequent DVT. For example, within the group already known to have slow flow, there was no further difference in velocities within the group to indicate who ultimately developed subsequent DVT.
Patients within the normal-and slow-flow groups were followed up to an average of 410 days from incident sonography (median, 266 days) and 439 days (median, 161 days), respectively. Sixty-eight of 493 in Diagnoses shown above represent any category of tumor that was seen in at least 10 patients in either group.
the normal-flow group and 75 of 482 in the slow-flow group had follow-up lower extremity sonography. The remainder of the patients underwent at least 1 standard follow-visit including history and physical examination, but most patients were seen multiple times during this follow-up period. Twenty-eight patients in the control group and 11 patients in the slow-flow group had a last documented encounter of less than 30 days from incident sonography without recorded death. Twenty-four and 34 patients died within 7 days of incident sonography in the slow-and normal-flow groups, respectively; none of these deaths were known to be attributed to pulmonary embolism/DVT. A total of 236 and 196 patients died within 6 months of the incident sonography in the control and slow-flow groups, respectively. In the slow-flow group, 79 patients had recent cross-sectional imaging with a finding to reasonably explain slow venous flow such as a compressing/infiltrating mass or stenosis. Of note, according to this same criterion, 44 patients with such findings were identified in the normal-flow group. Pertinent recent cross-sectional imaging was not present in 100 patients in the slow-flow group and 178 patients in the normal-flow group.
The radiologist's qualitative identification of slow venous flow was confirmed quantitatively; the measured peak venous velocities were significantly lower in the slow-flow group at each assessed venous level (P < .001) by an average of 9, 5, and 6 cm/s at the common femoral, femoral, and popliteal levels, respectively. The sum of the 3 venous level velocities resulted in the best cutoff for dichotomizing groups into normal versus slow venous flow using values of 42 cm/s in the left leg and 45 cm/s in the right leg (Tables 4 and 5 ). These dichotomized values, however, did not correlate with a statistical difference in the DVT rate.
Discussion
Venous stasis is commonly considered a risk factor for DVT, yet this association remains underevaluated in many patient groups. 10 Our study was a preliminary assessment of oncology patients in a tertiary care center who had documented slow venous flow in the lower extremities on sonography without initial DVT. The qualitative identification of slow venous flow in the lower extremities correlated with a statistically significantly increased rate of subsequent DVT development. To our knowledge, this work is the first study of the evaluation of slow venous flow by sonography as it relates to subsequent DVT development in oncology patients.
Although the concept of stasis leading to venous thrombosis has been described for centuries, there is limited literature on objectively measured slow deep venous flow and its potential correlation with DVT rates. In addition to our demonstration of a statistically significant increased rate of subsequent DVT development in the slow-venous flow group, there is further support of our data and this concept through the assessment of individual patients in the slow-flow group who developed DVT (Table 5) . Interestingly, in cases of subsequent DVT development in which a baseline bilateral examination was performed (n 5 6) and unilateral DVT developed (n 5 5), it most often developed in the leg with slower flow (Table 5 ). In 14 of 15 cases with unilateral baseline examinations, the subsequent DVT developed ipsilateral to the initially symptomatic leg that underwent sonographic evaluation. The latter case was confounded by only having a unilateral baseline sonographic No statistically significant differences between categories were found. a Full dose (prophylactic dose). b Defined as any finding such as external compression or stenosis that could potentially explain slow venous flow in the lower extremities. c Median (average).
examination, but this information may be useful in the development of future management algorithms. The results of our study suggest that implementation of increased imaging surveillance for patients with slow deep venous flow might be reasonable to consider. However, importantly, we observed a wide variation in the time to DVT development in both the slow-and normal-flow groups (Table 3) ; until further studies are performed, the utility of increased medical surveillance is of interest but is uncertain, especially as it pertains to various patient groups based on cancer diagnosis and other factors.
As slow deep venous flow becomes of more interest in research and clinical practice, identification on sonography and diagnostic reporting should increase. Empirically, based on our experience, there is limited reporting of slow venous flow on routine Doppler examinations performed for DVT evaluation. Perhaps some of this underreporting is related to the undefined nature of slow venous flow. Our study confirmed that the radiologist's qualitative identification of slow venous flow is accurate compared with quantitative spectral waveform measurements; importantly, this qualitative approach provided dichotomization of patients into clinically significant groups of slow and normal venous flow that were associated with different DVT rates. Although the best area under the curve was achieved when using the average of the 3 venous level velocities (14.5 cm/s average using both right and left leg data), the quantitative dichotomization did not reach statistical significance with respect to DVT rates. Given the qualitative diagnostic results, it is likely that a larger sample size would result in a statistically significant quantitative measure for stratifying patients.
Our study showed a higher percentage of men in the slow-flow group than in the normal-flow group; although a selection bias may have account for this finding, it is noted that the literature reports that the agestandardized incidence of first-time venous thromboembolism is slightly higher in men. 21 In addition, it was noted that the patients in the slow-flow group who developed subsequent DVT (n 5 21) included a higher In cases of positive DVT in which a baseline bilateral sonographic examination was done and unilateral DVT developed, it developed in the leg with slower flow in 3 of 4 patients; 1 case had bilateral DVT, and another had symmetrically slow flow in each leg. In cases in which the baseline was unilateral (not shown above), the subsequent DVT was always documented on that same side. CFV indicates common femoral vein; FV, femoral vein; and PV, popliteal vein. number of male patients; however, this group also had more patients who had received chemotherapy within 30 days of DVT identification, those with positive computed tomographic findings, and those who had undergone recent surgery (within 2 weeks). Although these factors were not statistically significant in our study, elucidation of these potential relationships would be of interest and likely useful.
Limitations of this study included its retrospective design. The potential for a selection bias was partially addressed by formulating our venous flow groups by including consecutive patients. However, our potential slow-venous flow group was created by a search of the radiology information reporting system for reports indicating slow venous flow. With this method, cases of slow flow would be missed if not mentioned in the report. Second, our standard lower extremity venous Doppler sonographic protocol evaluated the common femoral, femoral, and popliteal levels; the deep calf veins were assessed only when focal signs or symptoms were present below the knee. Therefore, asymptomatic distal DVT could have been missed on our review of each baseline and follow-up sonographic examination. In addition, although patients received clinical follow-up, it was varied in its time course, and many did not undergo sonographic follow-up. Nevertheless, given the typical close follow-up for our oncologic patient population, it would be unlikely that clinically important DVT would remain undiagnosed.
Although this study did assess various potential confounding variables, the small population size of patients with subsequent DVT formation limited the evaluation. Importantly, the groups with normal versus slow deep venous flow were remarkably similar, suggesting that they were valid groups for comparison. Specifically, there were no significant differences in important categories such as therapeutic or prophylactic use of anticoagulation (Tables 1-3 ). For this correlation to be further tested, each unique patient scenario including information such as tumor stage would require identification; there also needs to be control of more variables such as the duration of slow venous flow in a prospective manner with a larger sample size. It would be interesting and important to further determine the rate and timing of DVT formation with adjustment for these other factors.
In conclusion, the underlying pathophysiologic mechanism of slow venous flow in the lower extremities and DVT formation is multifactorial. Our study demonstrates that qualitative identification of slow venous flow is accurate, and this preliminary evaluation suggests that the presence of slow venous flow in the lower extremity deep veins indicates a small but increased risk of subsequent DVT development. Although further investigation is needed, it would be reasonable for these patients to be more closely monitored clinically and with a lower threshold for follow-up with venous Doppler sonography.
